Does higher serum 25-hydroxyvitamin D levels will harm bone mineral density?: a cross-sectional study

BMC Endocrine Disorders

Table 4 Subgroup analysis for the association between 25(OH)D and total BMD

Subgroup	BMD [β (95%CI)]	P for interaction
Age		0.9805
18-39.9	0.0003 (0.0002, 0.0004)
40–59	0.0003 (0.0002, 0.0004)
BMI		0.8292
<25	0.0003 (0.0002, 0.0004)
25–30	0.0003 (0.0002, 0.0004)
>30	0.0003 (0.0002, 0.0004)
RACE		0.6704
Mexican American	0.0004 (0.0001, 0.0007)
Other Hispanic	0.0003 (-0.0000, 0.0006)
Non-Hispanic White	0.0003 (0.0003, 0.0004)
Non-Hispanic Black	0.0002 (-0.0000, 0.0005)
Other Race - Including Multi-Racial	0.0004 (0.0001, 0.0006)

Data were presented as β(95%CI) P value
Abbreviations: 25(OH)D = 25-hydroxyvitamin D. BMD = Bone Mineral Density. BMI = Body Mass Index
Adjusted for gender, age, race, education level, family income to poverty ratio, body mass index, alcohol consumption frequency, serum cotinine, physical activity, sedentary activity, Sun Exposure, and HbA1C
The subgroup analysis was adjusted for all covariates, except the effect modifier

ISSN: 1472-6823